Significant Ownership of BROADWOOD PARTNERS, L.P.

Signature - Title
/s/ Neal C. Bradsher* - Neal C. Bradsher/President of Broadwood Capital, Inc.
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BROADWOOD PARTNERS, L.P..

Notify me when BROADWOOD PARTNERS, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BROADWOOD PARTNERS, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IMDX Insight Molecular Diagnostics Inc. Common Stock, no par value 37% $90,615,668 +$3,913,042 12,082,089 +4.5% Neal C. Bradsher 10 Feb 2026
STAA STAAR Surgical Company Common Stock, par value $0.01 per share 33% $266,309,246 +$11,051,812 16,149,742 +4.3% Neal C. Bradsher 13 Mar 2026
LCTX Lineage Cell Therapeutics, Inc. Common shares 23% $97,763,723 57,848,357 0% NEAL C. BRADSHER 12 Nov 2025

Schedules 13D/G Reported by BROADWOOD PARTNERS, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.